CTI BIOPHARMA CORP

CUSIP: 12648L106 Class: COM

PRELUDE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001387508)

Note: Option positions (PUT/CALL) are excluded.

Q4 2016
Shares 13,000 Value ($000) $5 Avg Close Range
Q3 2016
Shares 24,900 Value ($000) $9 Avg Close Range
Q2 2016
Shares 5,800 Value ($000) $2 Avg Close Range
Q3 2015
Shares 28,500 Value ($000) $42 Avg Close Range
Q2 2015
Shares 78,500 Value ($000) $153 Avg Close Range